Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo.
about
The reticulons: a family of proteins with diverse functionsMyelin suppresses axon regeneration by PIR-B/SHP-mediated inhibition of Trk activityOligodendrocyte-myelin glycoprotein and Nogo negatively regulate activity-dependent synaptic plasticityGlial inhibition of CNS axon regenerationAxon regeneration impediment: the role of paired immunoglobulin-like receptor BGrowing the growth cone: remodeling the cytoskeleton to promote axon regenerationC. elegans as a genetic model to identify novel cellular and molecular mechanisms underlying nervous system regenerationNeed for a paradigm shift in therapeutic approaches to CNS injuryPlexinA2 limits recovery from corticospinal axotomy by mediating oligodendrocyte-derived Sema6A growth inhibition.Assessment of functional recovery and axonal sprouting in oligodendrocyte-myelin glycoprotein (OMgp) null mice after spinal cord injuryMolecular basis of the interactions of the Nogo-66 receptor and its homolog NgR2 with myelin-associated glycoprotein: development of NgROMNI-Fc, a novel antagonist of CNS myelin inhibitionLDL receptor-related protein-1 is a sialic-acid-independent receptor for myelin-associated glycoprotein that functions in neurite outgrowth inhibition by MAG and CNS myelin.The nogo receptor family restricts synapse number in the developing hippocampusNgR1 and NgR3 are receptors for chondroitin sulfate proteoglycansNogo-receptors NgR1 and NgR2 do not mediate regulation of CD4 T helper responses and CNS repair in experimental autoimmune encephalomyelitisCharacterizing the neurite outgrowth inhibitory effect of Mani.Critical period for acoustic preference in mice.Engineering neuronal growth cones to promote axon regeneration over inhibitory molecules.Glycan-dependent binding of galectin-1 to neuropilin-1 promotes axonal regeneration after spinal cord injury.Autophagy induction stabilizes microtubules and promotes axon regeneration after spinal cord injury.Analysis of axonal regeneration in the central and peripheral nervous systems of the NG2-deficient mouse.Inhibitory activity of myelin-associated glycoprotein on sensory neurons is largely independent of NgR1 and NgR2 and resides within Ig-Like domains 4 and 5Soluble Nogo receptor down-regulates expression of neuronal Nogo-A to enhance axonal regeneration.Temporospatial expression and cellular localization of oligodendrocyte myelin glycoprotein (OMgp) after traumatic spinal cord injury in adult rats.Tuba1a gene expression is regulated by KLF6/7 and is necessary for CNS development and regeneration in zebrafish.The Nogo-Nogo receptor pathway limits a spectrum of adult CNS axonal growth.Functional axonal regeneration through astrocytic scar genetically modified to digest chondroitin sulfate proteoglycans.Selective temporal and regional alterations of Nogo-A and small proline-rich repeat protein 1A (SPRR1A) but not Nogo-66 receptor (NgR) occur following traumatic brain injury in the ratAssessment of Nogo-66 receptor 1 function in vivo after spinal cord injury.Nogo-66 receptor antagonist peptide (NEP1-40) administration promotes functional recovery and axonal growth after lateral funiculus injury in the adult ratEphA4 deficient mice maintain astroglial-fibrotic scar formation after spinal cord injury.Ephrin-B3 is a myelin-based inhibitor of neurite outgrowthBlockade of Nogo receptor ligands promotes functional regeneration of sensory axons after dorsal root crush.Myelin-associated glycoprotein and its axonal receptorsTraffic lights for axon growth: proteoglycans and their neuronal receptors.Mammalian target of rapamycin (mTOR) activation increases axonal growth capacity of injured peripheral nervesGenetic deletion and pharmacological inhibition of Nogo-66 receptor impairs cognitive outcome after traumatic brain injury in mice.Combined genetic attenuation of myelin and semaphorin-mediated growth inhibition is insufficient to promote serotonergic axon regeneration.Axon growth inhibition by RhoA/ROCK in the central nervous system.A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord.
P2860
Q21184131-FBCA3983-3A9D-40FF-8280-3BE2235BE939Q24294527-69E0C67D-1EF3-4646-A2AA-A0E6CA6CBD19Q24619952-9B5429D4-B35B-401F-BE53-F7B85231D202Q24648851-CA5BA082-C0DD-4E02-A434-5C34DDA506C1Q26781076-1B0FA4BF-3484-4D26-8A24-A279BB195721Q26829489-642FE964-37F3-4895-BCB6-CF207601B4BFQ27015955-4103F315-D09D-47BD-830F-951148EC2995Q27025042-B4EB01C1-F60F-48C8-940F-9A5C51236A9EQ27863424-90233DFD-6552-46A6-8112-9027FA344290Q28508918-8175B1A5-EA6B-4374-B226-01818D56F255Q28567486-1FE70614-6C03-4E8A-A7A9-424B4A5BA6F6Q28571064-05EC234C-5CAA-4C95-BB7D-8D3A0FC1B7B2Q28575724-E4A4CC1E-884B-4C31-BCD4-6B6E900225E3Q28594524-8387245F-A5F0-4E5F-8A06-55899A8569B5Q28742885-85FCC93D-9309-4D4E-BBF1-4B4EC87559F5Q30418920-8E35B601-D446-4FDD-8F3A-7610570ED04CQ30422042-6ED4CF4E-17F2-4382-8941-33F10C4375EEQ30499138-1781AA43-B106-4BDF-925A-237AEC3E7DDAQ30577639-327A4BA6-4BE9-4247-B0EE-6A77162BA128Q30819691-C52CAF1C-0F7D-427B-B651-A326CFBB2B29Q33300598-ED10C470-2CFF-4401-A1F7-3A7F0A396FDFQ33430262-8D471AE5-792D-49C4-B901-AAB3A2C4ED0DQ33594069-8D0E9071-7A0E-4B29-83F2-A7B05FF4C2E0Q33666560-6952A1E4-7FAD-44E0-9E45-35D7385E57D3Q33721932-179820A1-13A6-45E6-BE22-2243467CE5EBQ33767284-7592D4DF-471E-4F93-9A85-0E09C6B44E18Q33767291-63A2E28E-5C7D-4593-ADA1-DB686AE86E26Q33767902-86776A3C-32BF-4F8C-9CF2-24E710CF6FE5Q33774255-A7F666EF-A6F0-40AD-89FC-FE812A314C5AQ33783656-827EFBA8-1A17-46B8-B57C-31236E3937B8Q33828872-D39ED684-097A-436F-8860-F7A2C5BF2AB9Q33897550-ACF004E9-F46F-4943-B553-9F512511D28BQ33904882-B9470925-794E-4597-911F-77C7C154FBD5Q33943783-D556BAFB-E129-4AA9-AC5D-ED19AE0A228FQ34095872-2667725D-6C3E-4797-84CC-945DA85C529AQ34107374-6145BBE3-08C1-4BE4-B0FE-F57C106EB89FQ34142373-B30C6CE0-D314-439F-AD9A-9A7CECDBD77BQ34282446-3CC62563-C94C-4ED0-884F-3DB2D00CF7F7Q34384966-B8E1E2D7-9ECA-4613-8167-6FE65FE52C69Q34572480-F51AB2BB-A851-47BB-B776-363E1A72D811
P2860
Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Genetic deletion of the Nogo r ...... al tract regeneration in vivo.
@ast
Genetic deletion of the Nogo r ...... al tract regeneration in vivo.
@en
type
label
Genetic deletion of the Nogo r ...... al tract regeneration in vivo.
@ast
Genetic deletion of the Nogo r ...... al tract regeneration in vivo.
@en
prefLabel
Genetic deletion of the Nogo r ...... al tract regeneration in vivo.
@ast
Genetic deletion of the Nogo r ...... al tract regeneration in vivo.
@en
P2093
P2860
P356
P1476
Genetic deletion of the Nogo r ...... nal tract regeneration in vivo
@en
P2093
Binhai Zheng
Jasvinder Atwal
K Christopher Garcia
Lauren Case
Marc Tessier-Lavigne
Xiao-lin He
P2860
P304
P356
10.1073/PNAS.0409026102
P407
P577
2005-01-12T00:00:00Z